Author: Mukuntha Subburayan

Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.

The on-off nature of the pandemic “has led to a lot of the confusion and grumpiness,” says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.

Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.

KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.

Spun off from the ailing but not-quite-dead Build Back Better legislation, a popular proposal to cap out-of-pocket insulin costs at $35 a month faces tough political realities that could kill it.